Analyst IMS Investment Management Services Ltd. Trims Stock Position in iShares Biotechnology ETF $IBB

Core Insights - Analyst IMS Investment Management Services Ltd. reduced its stake in iShares Biotechnology ETF by 31.3%, owning 23,207 shares valued at $3,350,000 after selling 10,551 shares [2] - Institutional investors hold 62.45% of iShares Biotechnology ETF, with several hedge funds increasing their positions in the second quarter [3] Institutional Activity - Bronte Capital Management Pty Ltd. increased its holdings by 12.6%, now owning 295,346 shares valued at $37,000 after acquiring 32,947 shares [3] - Employees Retirement System of Texas purchased a new position worth $25,049,000 in the second quarter [3] - Atlantic Union Bankshares Corp and KFG Wealth Management LLC also made new purchases, with KFG increasing its stake by 4.8% [3] Stock Performance - iShares Biotechnology ETF opened at $170.76, with a 50-day moving average of $165.59 and a 200-day moving average of $147.36 [4] - The ETF has a 52-week low of $107.43 and a high of $174.40 [4] Dividend Information - The ETF recently increased its quarterly dividend to $0.1831 from $0.08, representing an annualized dividend of $0.73 and a yield of 0.4% [5][6]